Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

White matter lesions in Parkinson disease
Nicolaas I. Bohnen, Roger L. Albin
Nature Reviews Neurology (2011) Vol. 7, Iss. 4, pp. 229-236
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
Jon B. Toledo, Steven E. Arnold, Kevin Raible, et al.
Brain (2013) Vol. 136, Iss. 9, pp. 2697-2706
Open Access | Times Cited: 725
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Per Svenningsson, Eric Westman, Clive Ballard, et al.
The Lancet Neurology (2012) Vol. 11, Iss. 8, pp. 697-707
Closed Access | Times Cited: 490
Neuromechanical Principles Underlying Movement Modularity and Their Implications for Rehabilitation
Lena H. Ting, Hillel J. Chiel, Randy D. Trumbower, et al.
Neuron (2015) Vol. 86, Iss. 1, pp. 38-54
Open Access | Times Cited: 370
Aging of cerebral white matter
Huan Liu, Yuanyuan Yang, Yuguo Xia, et al.
Ageing Research Reviews (2016) Vol. 34, pp. 64-76
Open Access | Times Cited: 227
Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
Yung‐Shuan Lin, Wei‐Ju Lee, Shuu‐Jiun Wang, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 211
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
Jonathan Schulz, Gennaro Pagano, Juan Alberto Fernández Bonfante, et al.
Brain (2018) Vol. 141, Iss. 5, pp. 1501-1516
Open Access | Times Cited: 184
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Stéphane Prange, Hélène Klinger, Chloé Laurencin, et al.
Drugs & Aging (2022) Vol. 39, Iss. 6, pp. 417-439
Open Access | Times Cited: 85
New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102209-102209
Closed Access | Times Cited: 17
DTI correlates of distinct cognitive impairments in Parkinson's disease
Zhong Zheng, Shirag K. Shemmassian, Christopher Wijekoon, et al.
Human Brain Mapping (2013) Vol. 35, Iss. 4, pp. 1325-1333
Open Access | Times Cited: 171
Cognitive Impairment and Dementia in Parkinson’s Disease: Clinical Features, Diagnosis, and Management
Joana Meireles, João Massano
Frontiers in Neurology (2012) Vol. 3
Open Access | Times Cited: 158
Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage
Federica Agosta, Elisa Canu, Elka Stefanova, et al.
Human Brain Mapping (2013) Vol. 35, Iss. 5, pp. 1921-1929
Open Access | Times Cited: 151
White matter microstructure deteriorates across cognitive stages in Parkinson disease
Tracy R. Melzer, Richard Watts, Michael R. MacAskill, et al.
Neurology (2013) Vol. 80, Iss. 20, pp. 1841-1849
Closed Access | Times Cited: 142
Parkinson's disease motor subtypes and mood
David J. Burn, Sabine Landau, John V. Hindle, et al.
Movement Disorders (2011) Vol. 27, Iss. 3, pp. 379-386
Open Access | Times Cited: 139
Concomitant pathologies among a spectrum of parkinsonian disorders
Brittany N. Dugger, Charles H. Adler, Holly A. Shill, et al.
Parkinsonism & Related Disorders (2014) Vol. 20, Iss. 5, pp. 525-529
Open Access | Times Cited: 138
Large-scale GWAS reveals genetic architecture of brain white matter microstructure and genetic overlap with cognitive and mental health traits (n = 17,706)
Bingxin Zhao, Jingwen Zhang, Joseph G. Ibrahim, et al.
Molecular Psychiatry (2019) Vol. 26, Iss. 8, pp. 3943-3955
Open Access | Times Cited: 137
Increased CSF biomarkers of angiogenesis in Parkinson disease
Shorena Janelidze, Daniel Lindqvist, Veronica Francardo, et al.
Neurology (2015) Vol. 85, Iss. 21, pp. 1834-1842
Open Access | Times Cited: 133
Vascular parkinsonism—characteristics, pathogenesis and treatment
Amos D. Korczyn
Nature Reviews Neurology (2015) Vol. 11, Iss. 6, pp. 319-326
Closed Access | Times Cited: 132
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects
Jonathan Rubin, Cameron C. McIntyre, Robert S. Turner, et al.
European Journal of Neuroscience (2012) Vol. 36, Iss. 2, pp. 2213-2228
Open Access | Times Cited: 122
White-matter functional networks changes in patients with schizophrenia
Yuchao Jiang, Cheng Luo, Xuan Li, et al.
NeuroImage (2018) Vol. 190, pp. 172-181
Closed Access | Times Cited: 122
Early Alzheimer’s and Parkinson’s Disease Pathology in Urban Children: Friend versus Foe Responses—It Is Time to Face the Evidence
Lilian Calderón‐Garcidueñas, Maricela Franco-Lira, Antonieta Mora-Tiscareño, et al.
BioMed Research International (2013) Vol. 2013, pp. 1-16
Open Access | Times Cited: 117
Age-Related White Matter Changes
Yunyun Xiong, Vincent Mok
Journal of Aging Research (2011) Vol. 2011, pp. 1-13
Open Access | Times Cited: 116
White Matter Hyperintensities, Systemic Inflammation, Brain Growth, and Cognitive Functions in Children Exposed to Air Pollution
Lilian Calderón‐Garcidueñas, Antonieta Mora-Tiscareño, Martin Styner, et al.
Journal of Alzheimer s Disease (2012) Vol. 31, Iss. 1, pp. 183-191
Open Access | Times Cited: 113
Current Perspectives on Aerobic Exercise in People with Parkinson's Disease
Sabine Schootemeijer, Nicolien M. van der Kolk, Bastiaan R. Bloem, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1418-1433
Open Access | Times Cited: 103
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
David Bäckström, Jan Linder, Susanna Jakobson Mo, et al.
Neurology (2020) Vol. 95, Iss. 7
Open Access | Times Cited: 102
Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
Costanza Ferrari Bardile, Marta Garcia‐Miralles, Nicholas S. Caron, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 19, pp. 9622-9627
Open Access | Times Cited: 99
Page 1 - Next Page

Scroll to top